In CommitteeFiled Apr 16, 2026
Sponsor: Sen. Hassan, Margaret Wood [D-NH] (D)
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 16, 2026
Summary
The bill directs the Secretary of Health and Human Services to determine the exclusivity periods that apply to licensed biological products and to publish the expiration dates. It covers both new interchangeable biologics and existing reference products, with different reporting deadlines depending on when each product was licensed. The aim is to make exclusivity information transparent and encourage competition.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when S 4332 changes status, plus AI-powered summaries and stage predictions.
Sign up free